Detalhe da pesquisa
1.
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer.
Gut
; 63(2): 317-25, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23408352
2.
Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center.
Clin Gastroenterol Hepatol
; 12(7): 1119-26, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24333512
3.
Pathway-specific tumor suppression. Reduction of p27 accelerates gastrointestinal tumorigenesis in Apc mutant mice, but not in Smad3 mutant mice.
Cancer Cell
; 1(4): 355-68, 2002 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-12086850
4.
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
Prostate
; 69(12): 1257-69, 2009 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-19459176
5.
From discovery to the clinic: the novel DNA methylation biomarker (m)SEPT9 for the detection of colorectal cancer in blood.
Epigenomics
; 2(4): 575-85, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22121975
6.
p27kip1 deficiency impairs G2/M arrest in response to DNA damage, leading to an increase in genetic instability.
Mol Cell Biol
; 28(1): 258-68, 2008 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-17954563
7.
Tumor suppressor genetics.
Carcinogenesis
; 26(12): 2031-45, 2005 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-16150895
8.
p27(Kip1) (Cdkn1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screening.
Toxicol Pathol
; 31(4): 355-63, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-12851100